Spaulding Clinical Research said Monday it plans to partner with Aurora Health Care to open a research unit at Aurora Sinai Medical Center. The 18-bed unit will conduct Phase I clinical trials that test the safety of potential drugs. Read the full Milwaukee Journal Sentinel story here.
Journal Sentinel: Drug research firm to open clinical trial unit at Aurora Sinai
by Tech Council | Jun 25, 2013 | Featured, NEWSROOM, Tech Council News